SEC Form 4 · accession 0001493152-18-011209
Nobilis Health Corp. · HLTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Harry Joseph Fleming
Officer — Chief Executive Officer · Director
Period of report
Jun 28, 2018
Accepted (ET)
Aug 8, 2018 · 8:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001409916
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $1.22 | Jun 28, 2018 | A | 50,000 | A | Jun 28, 2018 | Jun 28, 2028 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1Options granted at an exercise price of US$1.22 per share (the average volume weighted average price ("VWAP") for the five business day period ending on the business day prior to the date of grant).
- F2The options vest on the date of grant.